Oncology Medical News about myelodysplastic syndromes

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Officials Question Approval Request for Leukemia Drug

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Hitting Chronic Lymphocytic Leukemia Where it Hurts

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Prognostic molecular markers in myelodysplastic syndromes
Expert Review of Hematology, 10/22/09

Neukirchen J et al. – New screening methods such as gene expression or single nucleotide polymorphism analysis are good candidates to find entrance in clinical practice in the future as they are useful tools in further elucidation of the underlying defects in myelodysplastic syndromes and the development of more specific classifications of the disease concerning risk assessment.

<< Previous
Late complications after hematopoietic stem cell transplantation

Next >>
Ethnic disparity in mortality after diagnosis of colorectal...